Kyxata J Code: J9278

Drug & Product Overview

HCPCS Descriptor Injection, carboplatin (avyxa), 1 mg

HCPCS Added Date April 1, 2026

Manufacturer Avyxa Pharma

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Multi-Dose

Dosage Form Injection

About Kyxata

Kyxata is a medication aligned to the HCPCS J Code: J9278 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Avyxa Pharma.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Package	Manufacturer	HCPCS Units	WAC	AWP
83831-0141-08	80 MG / 8 ML Kyxata Intravenous Injection 80 MG/8ML - 1 VIAL, MULTI-DOSE in 1 CARTON (83831-141-08) / 8 mL in 1 VIAL, MULTI-DOSE	Avyxa Pharma, LLC	80	$410.00 $5.125 / unit	$492.00 $6.15 / unit
83831-0142-50	500 MG / 50 ML Kyxata Intravenous Injection 500 MG/50ML - 1 VIAL, MULTI-DOSE in 1 CARTON (83831-142-50) / 50 mL in 1 VIAL, MULTI-DOSE	Avyxa Pharma, LLC	500	$2,562.50 $5.125 / unit	$3,075.00 $6.15 / unit

Effective 7/1/26 (WAC & AWP)

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Kyxata Pricing & Reimbursement

Historical Graphing and Billing Calculator

NDC Package

HCPCS Units

Markup / Markdown

%

Common:

Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.

Estimated Reimbursement

Carboplatin 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9278	Avyxa Pharma	Carboplatin	Injection, carboplatin (avyxa), 1 mg

Kyxata Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 48.9%

Avg. Days to File 7.3days

Avg. Days to Pay 24.0days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9278 claims analytics on FocalPoint →

Kyxata CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Kyxata Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced Ovarian Carcinoma

Drug Class

Platinum-based Drug [EPC]Platinum-containing Compounds [EXT]

Frequently Asked Questions

Is there an available Kyxata billing and coding guide?

Billing and coding information for Kyxata can be found through Avyxa Pharma, LLC. Visit Here →

Are there any available Kyxata patient assistance programs?

Kyxata patient assistance information can be found through Avyxa Pharma, LLC. Visit Here →

Where can I find Kyxata prescribing information?

Kyxata prescribing information can be found at the link below. Visit Here →

Where can I find Kyxata side effect information?

Our team has not yet identified a source of side effects information for Kyxata.

Does billing Kyxata require JZ/JW wastage modifiers?

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.